Bibliography
- Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis 2006;17(4):165-81
- Uter W, Gefeller O, Schwanitz HJ. Occupational dermatitis in hairdressing apprentices. Early-onset irritant skin damage. Curr Probl Dermatol 1995;23:49-55
- Lehucher-Michel MP, Koeppel MC, Lanteaume A, Sayag J. Dyshidrotic eczema and occupation: a descriptive study. Contact Dermatitis 2000;43(4):200-5
- Magina S, Barros MA, Ferreira JA, Mesquita-Guimaraes J. Atopy, nickel sensitivity, occupation, and clinical patterns in different types of hand dermatitis. Am J Contact Dermat 2003;14(2):63-8
- Meneghini CL, Angelini G. Contact and microbial allergy in pompholyx. Contact Dermatitis 1979;5(1):46-50
- Pitché P, Boukari M, Tchangai-Walla K. Factors associated with palmoplantar or plantar pompholyx: a case-control study. Ann Dermatol Venereol 2006;133(2):139-43
- Bryld LE, Agner T, Menne T. Relation between vesicular eruptions on the hands and tinea pedis, atopic dermatitis and nickel allergy. Acta Derm Venereol 2003;83(1):186-8
- Uyttendaele H, Obadiah J, Grossmann M. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy. J Drugs Dermatol 2003;2(3):337-41
- Vocks E, Plötz SG, Ring J. The dyshidrotic eczema area and severity index – a score developed for the assessment of dyshidrotic eczema. Dermatology 1999;198(3):265-9
- Veien NK, Ølholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone fuorate. Br J Dermatol 1999;140(5):882-6
- Pigatto PD, Gibelli E, Fumagalli M, et al. Disodium cromoglycate versus diet in the treatment and prevention of nickel-positive pompholyx. Contact Dermatitis 1990;22(1):27-31
- Jensen CS, Menné T, Lisby S, et al. Experimental systemic contact dermatitis from nickel: a dose-response study. Contact Dermatitis 2003;49(3):124-32
- Wollina U. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol 2007;8(3):157-73
- Berger TG, Duvic M, Van Voorhees AS, et al. American academy of dermatology association task force. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 2006;54:818-23
- Bieber T, Cork M, Ellis C, et al. Pediatric Advisory Committee of the Food and Drug Administration. Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology 2005;211(2):77-8
- Schnopp C, Remling R, Möhrenschlager M, et al. Topical tacrolimus (FK 506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002;46(1):73-7
- Schurmeyer-Horst F, Luger T, Böhm M. Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema. Dermatology 2007;214(1):99-100
- Belsito DV, Fowler JF Jr, Marks JG Jr, et al. Multicenter Investigator Group. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004;73(1):31-8
- Hanifin JM, Stevens V, Sheth P, Breneman D. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol 2004;105(3):545-53
- Scheinfeld N. Schools of pharmacology: retinoid update. J Drugs Dermatol 2006;5(9):921-2
- Wollina U, Karamfilov T. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left–right comparison. J Eur Acad Dermatol Venereol 2002;16(1):40-2
- Swartling C, Naver H, Lindberg M, Anveden I. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J Am Acad Dermatol 2002;47(5):667-71
- Bansal C, Omlin KJ, Hayes CM, Rohrer TE. Novel cutaneous uses for botulinum toxin type A. J Cosmet Dermatol 2006;5(3):268-72
- Kontochritopoulos G, Gregoriou S, Agiasofitou G, et al. Regression of relapsing dyshidtrotic eczema after treatment of concomitant hyperhidrosis with botulinum toxin-A. Dermatol Surg 2007;33(10):1289-90
- Glogau RG. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg 2007;33(1 Spec No):S76-80
- ClinicalTrials.gov. Dandelion juice in the treatment of dyshidrotic hand eczema. NCT00442091; 2007. Available from: http://clinicaltrials.gov/ct/gui/show/ NCT00442091
- Wollina U, Abdel Naser MB. Pharmacotherapy of pompholyx. Expert Opin Pharmacother 2004;5(7):1517-22
- Cheer SM, Foster RH. Alitretinoin. Am J Clin Dermatol 2000;1(5):307-14
- Ruzicka T, Larsen FG, Galewicz D, et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy. Results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004;140(12):1453-9
- Ruzicka T, Lynde CW, Jemec GBE, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008;158(4):808-17
- Riccioni G, Bucciarelli T, Mancini B, et al. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem 2007;14(18):1966-77
- Woodmansee DP, Simon RA. A pilot study examining the role of zileuton in atopic dermatitis. Ann Allergy Asthma Immunol 1999;83(6 Pt 1):548-52
- Carucci JA, Washenik K, Weinstein A, et al. The eleukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998;134(7):785-6
- Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol 2001;44(1):89-93
- Capella GL, Grigerio E, Altomare G. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur J Dermatol 2001;11(3):209-13
- Nettis E, Pannofino A, Fanelli M, et al. Efficacy and tolerability of montelukast as a therapeutic agent for severe atopic dermatitis in adults. Acta Derm Venereol 2003;83(1):297-320
- Rahman ML, Choudhury AM, Islam MM. Effectiveness of montelukast in the treatment of atopic dermatitis. Mymensingh Med J 2006;15(1):85-8
- Friedmann PS, Palmer R, Tan E, et al. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema. Clin Exp Allergy 2007;37(10):1536-40
- Dastidar SG, Rajagopal D, Ray A. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr Opin Investig Drugs 2007;8(5):364-72
- Bäumer W, Hoppmann J, Rundfeldt C, Kietzmann M. Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets 2007;6(1):17-26
- Jacobi A, Antoni C, Manger B, et al. Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2005;52(3 Pt 1):522-6
- Harper EG, Simpson EL, Takiguchi RH, et al. Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen. J Invest Dermatol 2007 [Epub ahead of print]
- Takiguchi R, Tofte S, Simpson B, et al. Efalizumab for severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol 2007;56(2):222-7
- Ogden S, Clayton TH, Goodfield MJD. Recalcitrant hand pompholyx: variable response to etanercept. Clin Exp Dermatol 2005;31(1):145-6
- Kägi MK, Heyer G. Efficacy of basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody in a patient with severe chronic atopic dermatitis. Br J Dermatol 2001;145(2):350-1
- Walker S, Monteil M, Phelan K, et al. Anti-IgE for chronic asthma. Cochrane Database Syst Rev 2003;3:CD003559
- MacConnachie AA, Smith CC. Pompholyx eczema as a manifestation of HIV infection, response to antiretroviral therapy. Acta Derm Venereol 2007;87(4):378-9
- Schmidt T, Abeck D, Boeck K, et al. UVA1 irradiation is effective in treatment of chronic vesicular hand eczema. Acta Derm Venereol 1998;78(4):318-9
- Polderman MC, Govaert JC, le Cessie S, Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 2003;28(6):584-7
- Petering H, Breuer C, Herbst R, et al. Comparision of localized high-dose UVA1 versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 2004;50(1):68-72
- Warshaw EM. Therapeutic options for chronic hand dermatitis. Dermatol Ther 2004;17:240-9
- Stambaugh MD, DeNittis AS, Wallner PE, Heymann WR. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis 2000;65(4):211-4
- Man I, Ibbotson SH, Ferguson J. Photoinduced pompholyx: a report of 5 cases. J Am Acad Dermatol 2004;50(1):55-60
- Krutmann J, Meve-Koenigs K, Ruzicka T, et al. Ultraviolet-free phototherapy. Photodermatol Photoimmunol Photomed 2005;21(2):59-61